Aligos Therapeutics, Inc.
SEC CIK 1799448 · ALGS · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Scopa James Paul | Director | filed 2021 - 2026 |
| Preston Heather | Director | filed 2024 - 2026 |
| Martell Bridget A | Director | filed 2021 - 2026 |
| Nuechterlein Carole | Director | filed 2020 - 2026 |
| Hirth Peter | Director | filed 2020 - 2026 |
| Chavez Margarita | Director | filed 2024 - 2026 |
| Blatt Lawrence | Director · President and CEO | filed 2020 - 2026 |
| Nielsen Jack | Director | filed 2020 - 2024 |
| Beigelman Leonid | Director · President | filed 2020 - 2023 |
| Woiwode Thomas | Director | filed 2020 - 2022 |
| Glaub Kathleen Sereda | Director | filed 2020 - 2020 |
| Moldt Peter | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Calhoun Lesley Ann | See Remarks | filed 2020 - 2026 |
| Symons Julian A. | See Remarks | filed 2020 - 2026 |
| Aneja Nikhil | Principal Accounting Officer | filed 2026 - 2026 |
| Achneck Hardean | Chief Medical Officer | filed 2024 - 2024 |
| Mcclure Matthew W. | Chief Medical Officer | filed 2022 - 2024 |
| Quan Lucinda Y. | See Remarks | filed 2020 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.